APP (Ab 668) Antilichaam

APP encodes a cell surface receptor and transmembrane precursor protein that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy) . Multiple transcript variants encoding several different isoforms have been found for this gene.

351

P05067

NP_000475.1

Human, Mouse, Rat

APP (Ab-668) antibody was raised against a peptide sequence around aa.666~670 (A-V-T-P-E) derived from Human APP.

Unconjugated

Primary Antibodies

Neuroscience

Antibodies were purified by affinity-chromatography using epitope-specific peptide.

1 mg/mL

Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

None

Blue Ice

Store antibody at -20˚ C for up to one year.

100 - 140 kDa

This antibody detects endogenous level of total APP protein.

Western Blot: 1:500~1:1000, Immunofluorescence: 1:100~1:200

APP

Amyloid beta (A4) precursor protein

Homo sapiens

Hung, A. Y. and Selkoe, D. J. (1994) EMBO J. 13, 534-542. Suzuki, T. et al. (1994) EMBO J. 13, 1114-1122Ando, K. et al. (1999) J. Neurosci. 19, 4421-4427. Iijima, K. I. et al. (2000) J. Neurochem. 75, 1085-1091

AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma, AAA

WB, IF

4502167

Liquid